STEM Stem Inc
- 1.300
- +0.030+2.36%
- 1.270
- -0.030-2.31%
Stem Inc News
Stem, Inc. (NYSE:STEM) Stock's 31% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Unfortunately for some shareholders, the Stem, Inc. (NYSE:STEM) share price has dived 31% in the last thirty days, prolonging recent pain. For any long-term shareholders, the last month ends a year
UBS Adjusts Price Target on Stem to $2.50 From $5, Maintains Buy Rating
Stem (STEM) has an average outperform rating and price target range of $1.50 to $11, according to analysts polled by Capital IQ. Price: 1.34, Change: +0.05, Percent Change: +3.88
Stem Is Maintained at Buy by UBS
Stem Is Maintained at Buy by UBS
Stem Price Target Cut to $2.50/Share From $5.00 by UBS
Stem Price Target Cut to $2.50/Share From $5.00 by UBS
UBS Maintains Buy on Stem, Lowers Price Target to $2.5
UBS analyst Jon Windham maintains Stem (NYSE:STEM) with a Buy and lowers the price target from $5 to $2.5.
Stem Inc(STEM.US) Officer Sells US$359.22K in Common Stock
$Stem Inc(STEM.US)$ Officer Carrington John Eugene sold 194.17K shares of common stock on May 2, 2024 at an average price of $1.85 for a total value of $359.22K.Source: Announcement What is statement
Stem Is Maintained at Neutral by Goldman Sachs
Stem Is Maintained at Neutral by Goldman Sachs
Goldman Sachs Maintains Neutral on Stem, Lowers Price Target to $2
Goldman Sachs analyst Brian Lee maintains Stem (NYSE:STEM) with a Neutral and lowers the price target from $2.5 to $2.
12 Industrials Stocks Moving In Monday's Pre-Market Session
GainersGraphex Gr (AMEX:GRFX) stock rose 16.5% to $0.27 during Monday's pre-market session. The market value of their outstanding shares is at $11.9 million. Richtech Robotics (NASDAQ:RR) stock rose 1
Institutional Owners May Consider Drastic Measures as Stem, Inc.'s (NYSE:STEM) Recent US$76m Drop Adds to Long-term Losses
Key Insights Significantly high institutional ownership implies Stem's stock price is sensitive to their trading actions A total of 24 investors have a majority stake in the company with 50% ownersh
RCAT, SMFL and NUVO Among Mid-day Movers
Stem Price Target Cut to $9.00/Share From $13.00 by Evercore ISI Group
Stem Price Target Cut to $9.00/Share From $13.00 by Evercore ISI Group
Stem Is Maintained at Market Perform by BMO Capital
Stem Is Maintained at Market Perform by BMO Capital
Bank of Montreal, Canada: Maintaining the Stem (STEM.US) rating, adjusted from unanimous market to consistent market rating, target price adjusted from $2.50 to $1.85.
Bank of Montreal, Canada: Maintaining the Stem (STEM.US) rating, adjusted from unanimous market to consistent market rating, target price adjusted from $2.50 to $1.85.
BMO Capital Maintains Market Perform on Stem, Lowers Price Target to $1.85
BMO Capital analyst Ameet Thakkar maintains Stem with a Market Perform and lowers the price target from $2.5 to $1.85.
Stem Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 22.64% BMO Capital $2.5 → $1.85 Maintains Market Perform 04/11/2024 32.58% Piper Sandler $3 → $
Earnings Call Summary | Stem Inc(STEM.US) Q1 2024 Earnings Conference
The following is a summary of the Stem, Inc. (STEM) Q1 2024 Earnings Call Transcript:Financial Performance:Stem, Inc. reported Q1 2024 revenue of $25 million, a decrease of 62% compared to Q1 2023 due
12 Industrials Stocks Moving In Friday's Pre-Market Session
GainersXPO (NYSE:XPO) stock moved upwards by 9.2% to $119.0 during Friday's pre-market session. The market value of their outstanding shares is at $13.8 billion. The company's, Q1 earnings came out to
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Shares of Apple Inc. (NASDAQ:AAPL) rose sharply in today's pre-market trading after the company reported better reported better-than-expected results for its second quarter.The company announced a $11
Stem Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results and Cut Its FY24 Revenue Guidance.
Stem Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results and Cut Its FY24 Revenue Guidance.
Analysis
Price Target
No Data
